Page last updated: 2024-11-02

pd 98059 and Hypereosinophilic Syndrome

pd 98059 has been researched along with Hypereosinophilic Syndrome in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, J1
Chan, LS1
Wong, CK2
Wong, NS1
Leung, KN1
Mak, NK1

Other Studies

1 other study available for pd 98059 and Hypereosinophilic Syndrome

ArticleYear
Effect of benzo[a]pyrene on the production of vascular endothelial growth factor by human eosinophilic leukemia EoL-1 cells.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2011, Volume: 30, Issue:3

    Topics: Benzo(a)pyrene; Carcinogens; Cell Line; Coculture Techniques; Endothelium, Vascular; Enzyme Inhibito

2011